CTLA4 and cancer: Furthermore, antibodies that block the immune inhibitory pathways, such as CTLA-4, PD-1, Tim-3 and so on, have provided a major treatment advance in patients with cancers and chronic infections27,31,32, according to our data, the reproductive safety must be a criterion considered in the assessment of immuno-therapeutic agents.